Search - tctmd.com

Displaying 121 - 140 of 193

Sort: Relevancy | Date

Presentation TCT 2017

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Presenter: Samir R. Kapadia, Sameer Gafoor

November 01, 2017

Presentation TCT 2017

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Presenter: Samir R. Kapadia, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Presenter: Samir R. Kapadia, Ashish Pershad

November 01, 2017

Presentation TCT 2017

Transseptal TMVR In MAC in a Patient With Septal Hypertrophy: Role of Pre-emptive Alcohol Septal Ablation

Presenter: Alfredo Trento, Mayra Guerrero

November 01, 2017

Presentation TCT 2017

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

Presenter: Vinayak Bapat, Maurice Buchbinder, Jaffar M Khan

October 31, 2017

Presentation TCT 2017

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

Presenter: Brij Maini, Petr Neuzil, Brian Courtney, MD

October 31, 2017

Presentation TCT 2017

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

Presenter: Brij Maini, Petr Neuzil, Christopher Capps, MD

October 31, 2017

Presentation TCT 2017

TCT 102: Five-Year Outcomes of Left Atrial Appendage Closure: Final Results of the Continued Access to PROTECT AF (CAP) Registry

Presenter: Brij Maini, Petr Neuzil, David R. Holmes Jr.

October 31, 2017

Presentation TCT 2017

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Presenter: Brij Maini, Petr Neuzil, Grzegorz Smolka, MD

October 31, 2017

Presentation TCT 2017

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Presenter: Christopher B. Granger, Horst Sievert, Vivek Y. Reddy

October 30, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

Presentation LAA 2017

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

Presenter: Vivek Y. Reddy

July 21, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

News Daily News

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Yael L. Maxwell

April 18, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day Three

Shelley Wood

March 19, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Presentation Miami Valves 2017

Alcohol Septal Ablation for TMVR-induced LVOT Obstruction and other tricks

Presenter: Mayra Guerrero

January 30, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

Advertisement

Selecting the Right LAA Closure Device Based on Patient Characteristics and LAA Anatomy: Occluder, Ligation, or Clipping

Is LAA Closure an Alternative to Triple Therapy for All Patients or Just Those at High Bleeding Risk? Current Dataset

Rationale and Potential Role for LAA Closure in the PCI and ACS Patient

Transseptal TMVR In MAC in a Patient With Septal Hypertrophy: Role of Pre-emptive Alcohol Septal Ablation

Frequency/Prevention/Treatment of LVOT Obstruction: Alcohol, Septal, Ablation, and LAMPOON

TCT 104: Initial Pre-clinical and Clinical Use of Mechanical Intracardiac Echocardiography System With 3D Viewing, Color Doppler, and Side-Viewing Capabilities

TCT 103: Long-Term Outcomes of Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16 Year Study

TCT 102: Five-Year Outcomes of Left Atrial Appendage Closure: Final Results of the Continued Access to PROTECT AF (CAP) Registry

TCT 101: Safety of Double Antiplatelet Therapy as an Alternative to Warfarin Plus Aspirin After Left Atrial Appendage Device Closure - Short-Term Results of WATCHMAN-DAPT Multi-Center Registry

Catheter Ablation and/or LAA Closure for Atrial Fibrillation: Competitive or Complementary?

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure?

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Live From Washington: ACC 2017, Day Three

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Alcohol Septal Ablation for TMVR-induced LVOT Obstruction and other tricks

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content